NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03783442,A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma,https://clinicaltrials.gov/study/NCT03783442,,COMPLETED,The purpose of this study is to evaluate the efficacy and safety of tislelizumab as first line treatment in combination with chemotherapy in participants with advanced unresectable/metastatic esophageal squamous cell carcinoma (ESCC).,YES,Esophageal Squamous Cell Carcinoma (ESCC),DRUG: Cisplatin|DRUG: Oxaliplatin|DRUG: Fluorouracil (5-FU)|DRUG: Capecitabine|DRUG: Paclitaxel|DRUG: Tislelizumab|DRUG: Placebo,"Overall Survival (OS), OS is defined as the time from the date of randomization until the date of death due to any cause, Up to approximately 3 years and 2 months (as of primary analysis data cut-off date of 28FEB2022)","Progression-Free Survival (PFS), PFS is defined as the time from the date of randomization to the date of first documentation of disease progression assessed by the investigator per RECIST v1.1 or death, whichever occurs first, Approximately 40 months from date of the first participant randomization|Objective Response Rate (ORR), ORR is defined as the proportion of participants whose best overall response (BOR) is complete response (CR) or partial response (PR) assessed by the investigator per RECIST v1.1, Approximately 40 months from date of the first participant randomization|Overall Survival (OS) in the PD-L1 Score â‰¥ 10% Subgroup, OS is defined as the time from the date of randomization until the date of death due to any cause, Approximately 40 months from date of the first participant randomization|Duration of Response (DOR), DOR is defined as the time from the first determination of an objective response until the first documentation of progression assessed by the investigator per RECIST v1.1 or death, whichever comes first, Approximately 40 months from date of the first participant randomization|Health-Related Quality of Life (HRQoL) Assessment of the Participant's Overall Health Status Using European Quality of Life-Core 30 Questionnaire Index (EORTC QLQ-C30), Approximately 40 months from date of the first participant randomization|Health-Related Quality of Life (HRQoL) Assessment of the Participant's Overall Health Status Using the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Esophageal Cancer Specific Module (EORTC QLQ-OES18), Approximately 40 months from date of the first participant randomization|Health-Related Quality of Life (HRQoL) Assessment of the Participant's Overall Health Status Using the Generic Health State Instrument European Quality of Life-5 Dimensions (EuroQol 5D EQ-5D-5L), Approximately 40 months from date of the first participant randomization|Number of Participants Experiencing Adverse Events (AEs), Approximately 40 months from date of the first participant randomization",,BeiGene,,ALL,"ADULT, OLDER_ADULT",PHASE3,649,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",BGB-A317-306|2018-000587-28|CTR20181013|JapicCTI-194741,2018-12-11,2022-02-28,2024-08-22,2018-12-21,2023-11-07,2024-10-26,"Smilow Cancer Hospital At Yale, New Haven, Connecticut, 06510, United States|Renovatio Clinical, The Woodlands, Texas, 77090, United States|Coffs Harbour Base Hospital, Coffs Harbour, New South Wales, 2450, Australia|St Vincents Hospital Melbourne, Fitzroy, Victoria, 3065, Australia|Institut Jules Bordet, Anderlecht, 1070, Belgium|Az Sint Jan Brugge, Brugge, 8000, Belgium|Grand Hopital de Charleroi Site Notre Dame, Charleroi, 6000, Belgium|UZ GENT, Gent, 9000, Belgium|University Hospitals Leuven, Leuven, 3000, Belgium|Chc Montlegia, Liege, 4000, Belgium|Anhui Provincial Hospital, Hefei, Anhui, 230000, China|Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital, Hefei, Anhui, 230088, China|The Second Hospital of Anhui Medical University, Hefei, Anhui, 230601, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|The Fifth Medical Center of Chinese Pla General Hospital, Beijing, Beijing, 100071, China|Beijing Cancer Hospital, Beijing, Beijing, 100142, China|Peking Union Medical College Hospital, Beijing, Beijing, 100730, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350005, China|Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China|Quanzhou First Affliated Hospital of Fujian Medical University, Quanzhou, Fujian, 362000, China|The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China|Zhongshan Hospital Xiamen University, Xiamen, Fujian, 361004, China|The First Affiliated Hospital, Sun Yat Sen University, Guangzhou, Guangdong, 510080, China|The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, 510405, China|Guangdong Province Traditional Chinese Medical Hospitsal, Guangzhou, Guangdong, 510655, China|The Sixth Affiliated Hospital, Sun Yat Sen University, Guangzhou, Guangdong, 510655, China|Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, 515031, China|The Tumor Hospital Affiliated to Guangxi Medical University, Nanning, Guangxi, 530021, China|Hainan General Hospital, Haikou, Hainan, 570206, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, China|The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, 453100, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China|Hubei Cancer Hospital, Wuhan, Hubei, 430079, China|Xiangyang Central Hospital, Xiangyang, Hubei, 441021, China|Hunan Cancer Hospital, Changsha, Hunan, 410013, China|The First Peoples Hospital of Changzhou, Changzhou, Jiangsu, 213000, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|Nantong Tumor Hospital Branch North, Nantong, Jiangsu, 226000, China|Affiliated Hospital of Jiangnan University North Campus (Wuxi Fourth Peoples Hospital ), Wuxi, Jiangsu, 214062, China|The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China|The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China|Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, 110042, China|Shandong Cancer Hospital, Jinan, Shandong, 250117, China|Linyi Cancer Hospital, Linyi, Shandong, 276001, China|Weifang Peoples Hospital, Weifang, Shandong, 261000, China|Fudan University Shanghai Cancer Center, Shanghai, Shanghai, 200000, China|Shanxi Provincial Peoples Hospital, Taiyuan, Shanxi, 030012, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, 300060, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|Fakultni Thomayerova Nemocnice, Praha, 140 59, Czechia|Chru de Brest Hospital Morvan, Brest, 29200, France|Chu Besancon Hopital Jean Minjoz, Doubs, 25030, France|Hopital Franco Britannique, LevalloisPerret, 92300, France|Centre Oscar Lambret, Lille, 59000, France|Centre Leon Berard, Lyon Cedex, 69373, France|Hopital Saint Antoine Service Dhepato Gastro Enterologie, Paris Cedex, 75012, France|Hopital Europeen Georges Pompidou, Paris, 75015, France|Chu Bordeaux Hopital Haut Leveque, Pessac, 33600, France|Chu de Poitiers Site de La Mileterie, Poitiers, 86000, France|Centre de Lutte Contre Le Cancer Institut de Cancerologie de Louest Rene Gauducheau, SaintHerblain, 44805, France|Universitatsklinikum Hamburg Eppendorf, Hamburg, 20251, Germany|Slk Kliniken Heilbronn Gmbh Klinik Fur Radiologie, Minimalinvasive Therapien Und Nuklearmedizin, Heilbronn, 74078, Germany|Universitares Krebszentrum Leipzig, Leipzig, 04103, Germany|Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst, Meldola, 47014, Italy|Istituto Europeo Di Oncologia, Milano, 20141, Italy|Istituto Nazionale Tumori Fondazione G Pascale, Napoli, 80131, Italy|Iov Istituto Oncologico Veneto Irccs, Padova, 35128, Italy|Azienda Ospedaliera Universitaria Delle Marche, Torrette, 60020, Italy|Akita University Hospital, Akitashi, Akita, 010-8543, Japan|National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan|National Hospital Organization Kyushu Medical Center, Fukuokacity, Fukuoka, 810-8563, Japan|Nho Kyushu Cancer Center, Fukuokashi, Fukuoka, 811-1395, Japan|Hyogo Cancer Center, Akashi, Hyogo, 673-8558, Japan|Johas Kansai Rosai Hospital, Amagasakishi, Hyogo, 660-8511, Japan|Kanagawa Cancer Center, Yokohamashi, Kanagawa, 241-8515, Japan|Osaka International Cancer Institute, Osakashi, Osaka, 541-8567, Japan|Osaka University Hospital, Suitashi, Osaka, 565-0871, Japan|Saitama Cancer Center, Kitaadachigun, Saitama, 362-0806, Japan|National Cancer Center Hospital, Chuoku, Tokyo, 104-0045, Japan|Hiroshima University Hospital, Hiroshima, 734-8551, Japan|Kumamoto University Hospital, Kumamoto, 860-8556, Japan|University Hospital, Kyoto Prefectural Univ of Medicine, Kyoto, 602-8566, Japan|Niigata Cancer Center Hospital, Niigata, 951-8566, Japan|Keimyung University Dongsan Hospital, Dalseogu, Daegu Gwang'yeogsi, 42601, Korea, Republic of|Cha Bundang Medical Center, Cha University, Gyeonggido, Gyeonggi-do, 13496, Korea, Republic of|Seoul National University Bundang Hospital, Seongnamsi, Gyeonggi-do, 13620, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Incheon Gwang'yeogsi, 21565, Korea, Republic of|Chonnam National University Hwasun Hospital, HwasunGun, Jeollanam-do, 58128, Korea, Republic of|Asan Medical Center, Seoul, Seoul Teugbyeolsi, 05505, Korea, Republic of|The Catholic University of Korea, Seoul St Marys Hospital, Seoul, Seoul Teugbyeolsi, 06591, Korea, Republic of|Smg Snu Boramae Medical Center, Seoul, Seoul Teugbyeolsi, 07061, Korea, Republic of|Korea University Guro Hospital, Seoul, Seoul Teugbyeolsi, 08308, Korea, Republic of|Samsung Medical Center Hematology Oncology, Seoul, Seoul Teugbyeolsi, 135-740, Korea, Republic of|Szpital Specjalist W Brzozowie,Podkarpacki Osrodek Onkologiczny, Brzozow, 36-200, Poland|Szpital Wojewodzki Im Mikoaja Kopernika W Koszalinie, Koszalin, 75-581, Poland|Spzoz Mswia Z Warminsko Mazurskim Centrum Onkologii, Olsztyn, 10-228, Poland|Narodowy Instytut Onkologii Im Marii Skodowskiej Curie Pastwowy Instytut Badawczy, Warszawa, 02-034, Poland|Institutul Oncologic Prof Dr Ion Chiricuta Cluj Napoca, ClujNapoca, 400015, Romania|Medisprof Cancer Center, ClujNapoca, 400641, Romania|Radiotherapy Center Cluj, ClujNapoca, 407280, Romania|Sc Centrul de Oncologie Sf Nectarie Srl, Craiova, 200347, Romania|Arkhangelsk Regional Clinical Oncological Dispensary, Arkhangelsk, Arkhangel'skaya Oblast', 163045, Russian Federation|Rbih Ivanovo Regional Oncological Dispensary, Ivanovo, Ivanovskaya Oblast', 153040, Russian Federation|State Budget Healthcare Institution Leningrad Regional Clinical Oncologic Dispensary, Kuzmolovsky, Leningradskaya Oblast', 188663, Russian Federation|Orenburg Regional Clinical Oncology Center, Orenburg, Orenburgskaya Oblast', 460021, Russian Federation|Rostov State Medical University, RostovnaDonu, Rostovskaya Oblast', 344022, Russian Federation|Pavlov First Saint Petersburg State Medical University, SaintPetersburg, Sankt-Peterburg, 197022, Russian Federation|Fsbi National Medical Research Center For Oncology Na Nn Petrov of the Moh of the Rf, SaintPetersburg, 197758, Russian Federation|Hospital Universitario Vall Dhebron, Barcelona, 08035, Spain|Institut Catala Doncologia, Barcelona, 08908, Spain|Hospital Clinic de Barcelona, Barcelona, 8036, Spain|Hospital General Universitario Gregorio Maranon, Madrid, 28007, Spain|Hospital Regional Universitario de Malaga, Malaga, 29010, Spain|Hospital Universitario Central de Asturias, Oviedo, 33011, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Chiayi Chang Gung Memorial Hospital, Chiayi, 61363, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|Chi Mei Medical Center, Tainan, 710, Taiwan|Chi Mei Hospital Liouying, Tainan, 736, Taiwan|The Christie Hospital, Greater Manchester, M20 4BX, United Kingdom|Guys and St Thomas Hospital Nhs Foundation Trust, London, SE1 9RT, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/42/NCT03783442/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/42/NCT03783442/SAP_001.pdf"
